Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
New money for old drugs: COVID-19 is not a profit-making opportunity
OpinionFirst published in Way magazine in Thai. To try to limit the catastrophic impact of COVID-19, a huge amount of...
Read more about New money for old drugs: COVID-19 is not a profit-making opportunity
-
Thai civil society opposes patent on an influenza drug, now used for COVID-19
NewsFavipiravir, originally approved as an influenza drug, is being used to treat COVID-19 patients with pneumonia, alongside anti-malarial and anti-retroviral...
Read more about Thai civil society opposes patent on an influenza drug, now used for COVID-19
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
Call to action News Press releaseThis week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
Read more about Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
NewsHumanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
Read more about Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
-
Danylo: Positive attitudes start with teaching – and effective HIV treatment
InterviewDanylo (name changed), 18, shares information about HIV with his university friends in Cherkassy, Ukraine. For example, “that HIV is...
Read more about Danylo: Positive attitudes start with teaching – and effective HIV treatment
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
News Press releaseDolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
Vera: HIV targets won’t be met without gender equality and accessible treatment
InterviewOn the day that new research is published, showing that countries are being overcharged by $34 billion a year for HIV drugs, Vera Varyga,...
Read more about Vera: HIV targets won’t be met without gender equality and accessible treatment
-
New data: Treat HIV for just four weeks of global pharmaceutical sales
News Press releaseThe Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
Read more about New data: Treat HIV for just four weeks of global pharmaceutical sales
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
NewsActivists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...
Read more about AIDS 2020 leadership workshop: Strategies for lowering drug prices
-
COVID-19: Another of Gilead’s FIVE patent applications on remdesivir is opposed in Argentina
NewsOur campaign partner, Fundación GEP, has filed a second patent opposition against one of Gilead’s numerous patent applications for the...
